ArticleBMC infectious diseases2026
Etiological landscape and co-infection dynamics in Acute Respiratory Infections (ARIs): insights from a multicenter outpatient study in Yunnan, China.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundARIs pose significant health risks, especially among children, elderly, and immunocompromised populations. This study investigated the etiological spectrum and epidemiological features of ARIs in Yunnan Province from December 2023 to February 2025.
methodsThroat swab samples and demographic information of ARI patients were collected from fever clinics of 23 sentinel hospitals in Yunnan Province every two weeks during the study period. Twenty-eight respiratory pathogens (13 viruses, 13 bacteria and 2 fungi) were detected by real-time PCR, and their overall detection rate, age distribution, seasonal variation and pathogen interactions were analyzed.
resultsFrom the 2,386 patient samples tested, the overall detection rate for viruses and Mycoplasma pneumoniae (MP) was 33.86%, while bacteria and fungi were detected in 63.16% of samples. The most frequently detected pathogens varied by age group. Influenza A virus (IAV) and Human rhinovirus (HRV) were among the three most frequently detected viral pathogens across four age groups. Respiratory syncytial virus (RSV) showed the highest positivity rate (12.61%) in the 5–14 years age group and the second-highest rate (14.29%) in children under 5 years. Integrated modeling data revealed distinct temporal patterns among five respiratory pathogens: IAV exhibited bimodal winter peaks, Severe acute respiratory syndrome coronavirus (SARS-CoV-2) a single spring peak, while RSV and HRV showed dispersed low-intensity activity. The cross-correlation analysis indicates a significant short-term temporal correlation between IAV and SARS-CoV-2, limited to lags within ± 0.42 months. Among cases positive for IAV, SARS-CoV-2, or MP, co-infection rates with other tested pathogens (including a panel of respiratory viruses and MP) were 13.26%, 10.88%, and 18.88%, respectively. In the pairwise logistic regression analysis of pathogen co-detection, both IAV and SARS-CoV-2 were significant positively correlated with Aspergillus (False Discovery Rate (FDR)-adjusted p < 0.05).
conclusionsPathogens of ARI patients across Yunnan since late 2023 exhibited distinct seasonal fluctuations, diverse population susceptibility, and widespread co-infections. Statistically significant positive correlations with Aspergillus were observed for both SARS-CoV-2 and IAV. Therefore, we recommend the establishment of a seasonal, multi-pathogen surveillance and early warning system, coupled with enhanced clinical protocols for the management of coinfections, particularly among vulnerable populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.